Literature DB >> 24734939

Recent developments and best practice in brachytherapy treatment planning.

C D Lee1.   

Abstract

Brachytherapy has evolved over many decades, but more recently, there have been significant changes in the way that brachytherapy is used for different treatment sites. This has been due to the development of new, technologically advanced computer planning systems and treatment delivery techniques. Modern, three-dimensional (3D) imaging modalities have been incorporated into treatment planning methods, allowing full 3D dose distributions to be computed. Treatment techniques involving online planning have emerged, allowing dose distributions to be calculated and updated in real time based on the actual clinical situation. In the case of early stage breast cancer treatment, for example, electronic brachytherapy treatment techniques are being used in which the radiation dose is delivered during the same procedure as the surgery. There have also been significant advances in treatment applicator design, which allow the use of modern 3D imaging techniques for planning, and manufacturers have begun to implement new dose calculation algorithms that will correct for applicator shielding and tissue inhomogeneities. This article aims to review the recent developments and best practice in brachytherapy techniques and treatments. It will look at how imaging developments have been incorporated into current brachytherapy treatment and how these developments have played an integral role in the modern brachytherapy era. The planning requirements for different treatments sites are reviewed as well as the future developments of brachytherapy in radiobiology and treatment planning dose calculation.

Entities:  

Mesh:

Year:  2014        PMID: 24734939      PMCID: PMC4453147          DOI: 10.1259/bjr.20140146

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  117 in total

1.  Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.

Authors:  Jean Pouliot; Yongbok Kim; Etienne Lessard; I-Chow Hsu; Daniel B Vigneron; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

2.  American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.

Authors:  Brian J Davis; Eric M Horwitz; W Robert Lee; Juanita M Crook; Richard G Stock; Gregory S Merrick; Wayne M Butler; Peter D Grimm; Nelson N Stone; Louis Potters; Anthony L Zietman; Michael J Zelefsky
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

3.  Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Authors:  Gerard Morton; Andrew Loblaw; Patrick Cheung; Ewa Szumacher; Manraj Chahal; Cyril Danjoux; Hans T Chung; Andrea Deabreu; Alexandre Mamedov; Liying Zhang; Raxa Sankreacha; Eric Vigneault; Colvin Springer
Journal:  Radiother Oncol       Date:  2011-09-14       Impact factor: 6.280

4.  The American Brachytherapy Society consensus statement for accelerated partial breast irradiation.

Authors:  Chirag Shah; Frank Vicini; David E Wazer; Douglas Arthur; Rakesh R Patel
Journal:  Brachytherapy       Date:  2013-04-23       Impact factor: 2.362

5.  MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.

Authors:  Jacob Christian Lindegaard; Lars Ulrik Fokdal; Søren Kynde Nielsen; Jens Juul-Christensen; Kari Tanderup
Journal:  Acta Oncol       Date:  2013-08-21       Impact factor: 4.089

6.  A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy.

Authors:  Rakesh R Patel; Stewart J Becker; Rupak K Das; Thomas R Mackie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-30       Impact factor: 7.038

7.  Results of permanent prostate brachytherapy, 13 years of experience at a single institution.

Authors:  Jan J Battermann; Tom A Boon; Marinus A Moerland
Journal:  Radiother Oncol       Date:  2004-04       Impact factor: 6.280

8.  Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation.

Authors:  Daniel J Ferraro; Adam A Garsa; Todd A DeWees; Julie A Margenthaler; Michael Naughton; Rebecca Aft; William E Gillanders; Timothy Eberlein; Melissa A Matesa; Imran Zoberi
Journal:  Radiat Oncol       Date:  2012-03-29       Impact factor: 3.481

9.  High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity.

Authors:  Peter Hoskin; Ana Rojas; Peter Ostler; Robert Hughes; Roberto Alonzi; Gerry Lowe; Linda Bryant
Journal:  Radiother Oncol       Date:  2013-11-11       Impact factor: 6.280

10.  A commissioning procedure for breast intracavitary electronic brachytherapy systems.

Authors:  Jessica Hiatt; Gene Cardarelli; Jaroslaw Hepel; David Wazer; Edward Sternick
Journal:  J Appl Clin Med Phys       Date:  2008-06-23       Impact factor: 2.102

View more
  4 in total

Review 1.  Electronic brachytherapy--current status and future directions.

Authors:  D J Eaton
Journal:  Br J Radiol       Date:  2015-03-06       Impact factor: 3.039

Review 2.  A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.

Authors:  Yousif A M Yousif; Alexander F I Osman; Mohammed A Halato
Journal:  Phys Eng Sci Med       Date:  2021-06-17

3.  Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose.

Authors:  Łukasz Kuncman; Sławomir Kozłowski; Andrzej Pietraszek; Malwina Pietrzykowska-Kuncman; Justyna Danielska; Janusz Sobotkowski; Jolanta Łuniewska-Bury; Jacek Fijuth
Journal:  J Contemp Brachytherapy       Date:  2016-07-01

Review 4.  UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016.

Authors:  Gemma Corey; A B Mohamed Yoosuf; Geraldine Workman; Monica Byrne; Darren M Mitchell; Suneil Jain
Journal:  J Contemp Brachytherapy       Date:  2018-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.